CNS Pharmaceuticals, Inc.
CNSP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001729427
In the last 90 days, CNS Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 11 institutions reported holding it in 13F filings for Q2 2026, worth $1.34M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in CNS Pharmaceuticals, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +3 vs. Q1 2022
- Shares held
- 1.23M
- −499.6K (−28.8%) vs. Q1 2022
- Total value
- $343.5K
- −$245.5K (−41.7%) vs. Q1 2022
- New holders
- 7
- 4 more added
- Sold out
- 4
- 2 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNSP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 11 | $1.34M |
| Q1 2026 | 12 | $348.7K |
| Q4 2025 | 10 | $652.4K |
| Q3 2025 | 8 | $221.5K |
| Q2 2025 | 11 | $421.8K |
| Q1 2025 | 7 | $55.2K |
| Q4 2024 | 21 | $297.3K |
| Q3 2024 | 14 | $75.3K |
| Q2 2024 | 10 | $227.8K |
| Q1 2024 | 19 | $351.0K |
| Q4 2023 | 16 | $425.3K |
| Q3 2023 | 12 | $131.7K |
| Q2 2023 | 12 | $234.4K |
| Q1 2023 | 13 | $190.5K |
| Q4 2022 | 10 | $335.0K |
| Q3 2022 | 21 | $232.0K |
| Q2 2022 | 23 | $343.5K |
| Q1 2022 | 20 | $589.0K |
| Q4 2021 | 24 | $828.0K |
| Q3 2021 | 20 | $1.44M |
| Q2 2021 | 20 | $2.64M |
| Q1 2021 | 19 | $3.04M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding CNS Pharmaceuticals, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Gradient Investments LLC | 200 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 1,000 | $0 | 0.00% | 00.0% | Unchanged |
| Urban Wealth Management, LLC | 100 | $0 | 0.00% | +100 | New |
| Wells Fargo & Company | 12,196 | $3.00K | 0.00% | +33+0.3% | Added |
| Alpha Cubed Investments, LLC | 10,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 10,384 | $3.00K | 0.00% | +10,384 | New |
| Prime Capital Investment Advisors, LLC | 10,727 | $3.00K | 0.00% | +10,727 | New |
| HighTower Advisors, LLC | 16,000 | $4.00K | 0.00% | +2,500+18.5% | Added |
| Citigroup Inc | 13,400 | $4.00K | 0.00% | +13,400 | New |
| StoneX Group Inc. | 15,921 | $4.46K | 0.00% | +15,921 | New |
| Commonwealth Equity Services, LLC | 20,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| United Capital Financial Advisers, LLC | 18,944 | $5.00K | 0.00% | +18,944 | New |
| Citadel Advisors LLC | 20,721 | $6.00K | 0.00% | −34,510−62.5% | Reduced |
| State Street Corp | 19,645 | $6.00K | 0.00% | 00.0% | Unchanged |
| Cambridge Investment Research Advisors, Inc. | 25,250 | $7.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 29,007 | $8.00K | 0.00% | +582+2.0% | Added |
| Northern Trust Corp | 32,094 | $9.00K | 0.00% | 00.0% | Unchanged |
| FSM Wealth Advisors, LLC | 40,000 | $10.0K | 0.01% | +40,000 | New |
| Geode Capital Management, LLC | 129,016 | $36.0K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 178,184 | $50.0K | 0.00% | +66,435+59.5% | Added |
| Bank of New York Mellon Corp | 203,548 | $57.0K | 0.00% | −31,344−13.3% | Reduced |
| Vanguard Group Inc | 427,703 | $120.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −506,532−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −41,087−100.0% | Sold out |
| Beacon Financial Advisory LLC | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −25,143−100.0% | Sold out |